Lioresal

Chronic Pain, Clonus, severe spinal cord origin Spasticity + 11 more
Treatment
20 Active Studies for Lioresal

What is Lioresal

BaclofenThe Generic name of this drug
Treatment SummaryBaclofen is a muscle relaxer that is used to relieve painful or uncomfortable muscle spasms caused by certain medical conditions. It is often prescribed to people with spinal cord injuries to reduce muscle spasticity. There is currently not enough evidence to determine whether baclofen is effective in treating alcohol withdrawal. This drug was approved by the FDA in 1992.
Lioresalis the brand name
image of different drug pills on a surface
Lioresal Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Lioresal
Baclofen
1977
325

Effectiveness

How Lioresal Affects PatientsBaclofen is a drug that helps with muscle relaxation. It works by decreasing the amount of excitatory signals sent from pre-synaptic neurons and increasing the amount of inhibitory signals sent from post-synaptic neurons. Most commonly, it is taken orally. In one study, it was found to be more effective at reducing spasticity when given directly into the spinal cord than when taken orally. Baclofen can cause drowsiness, poor balance, slow breathing, and a decrease in heart rate. It also can help reduce pain and increase stomach acid production. Additionally, baclofen has anti-inflammatory
How Lioresal works in the bodyBaclofen works by blocking signals between the brain and muscles. It binds to GABA receptors, which are found on both pre- and post-synaptic neurons. This blocks the action potentials which would normally be sent to the muscles, leading to relaxation of spasticity. It also causes an influx of potassium into the neuron, which further helps to relax the muscles. Baclofen may also act on some voltage-gated calcium channels, but the clinical significance of this is still unclear.

When to interrupt dosage

The measure of Lioresal is contingent upon the identified affliction, including Spasticity, Multiple Sclerosis and Joint Pain. The dosage is subject to the method of delivery (e.g. Injection - Intrathecal or Tablet - Oral) referenced in the table below.
Condition
Dosage
Administration
Spinal Cord Diseases
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Muscle Spasticity
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Multiple Sclerosis
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Clonus
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
severe spinal cord origin Spasticity
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
severe cerebral origin Spasticity
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Muscle Spasticity
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Spinal Cord Injury
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Cerebral Palsy
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Concussion
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Spasm
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Alcoholism
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Muscle Rigidity
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension
Chronic Pain
10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL
Tablet, Tablet - Oral, Kit - Topical, Kit, Solution, , Oral, Topical, Injection, Intrathecal, Injection - Intrathecal, Injection, solution, Injection, solution - Intrathecal, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Intrathecal, Solution - Oral, Granule - Oral, Granule, Suspension - Oral, Suspension

Warnings

Lioresal Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Baclofen may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Lioresal.
Common Lioresal Drug Interactions
Drug Name
Risk Level
Description
Azelastine
Major
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Ethanol
Major
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Oliceridine
Major
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Baclofen is combined with Oliceridine.
Thalidomide
Major
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
1,2-Benzodiazepine
Minor
Baclofen may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine.
Lioresal Toxicity & Overdose RiskThe lowest toxic dose of baclofen in rats is 145 mg/kg. Symptoms of a baclofen overdose may include confusion, sleepiness, low body temperature, shallow or slow breathing, coma, and seizures. Other rare symptoms can include changes in blood pressure, a slow or fast heartbeat, and vomiting. If someone has overdosed on baclofen, immediate medical attention should be sought. If the patient is awake, vomiting should be induced and their stomach contents should be removed. Unconscious patients should not be encouraged to vomit.
image of a doctor in a lab doing drug, clinical research

Lioresal Novel Uses: Which Conditions Have a Clinical Trial Featuring Lioresal?

451 active studies are currently investigating Lioresal's potential to reduce Clonus, Spasm and severe Spasticity of cerebral origin.
Condition
Clinical Trials
Trial Phases
Spinal Cord Injury
68 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Early Phase 1, Phase 1
Spinal Cord Diseases
10 Actively Recruiting
Not Applicable, Phase 2
Muscle Spasticity
0 Actively Recruiting
Alcoholism
7 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Concussion
99 Actively Recruiting
Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1, Phase 4
Multiple Sclerosis
127 Actively Recruiting
Phase 3, Not Applicable, Phase 4, Phase 2, Phase 1, Early Phase 1
Cerebral Palsy
0 Actively Recruiting
Chronic Pain
129 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1
severe spinal cord origin Spasticity
0 Actively Recruiting
severe cerebral origin Spasticity
0 Actively Recruiting
Muscle Spasticity
0 Actively Recruiting
Clonus
0 Actively Recruiting
Spasm
0 Actively Recruiting
Muscle Rigidity
0 Actively Recruiting

Lioresal Reviews: What are patients saying about Lioresal?

4.3Patient Review
4/21/2009
Lioresal for Muscle Spasms caused by a Spinal Disease
At first, I felt really lightheaded and confused after taking this drug. But now, I can't imagine living without it. It's made life so much easier for me.
4Patient Review
9/23/2008
Lioresal for Muscle Spasms caused by a Spinal Disease
The medicine works quickly, but the effects don't last very long. Sometimes I have to take a few extra doses when my disease is acting up, but that's to be expected.
2.3Patient Review
4/13/2010
Lioresal for Muscle Spasms caused by a Spinal Disease
I've been taking this medication for a month now and have yet to see any improvements. My doctor said it would help me with my muscle spasms and cramping, but I still experience those issues just as frequently.
2Patient Review
1/1/2011
Lioresal for Abnormal Movements of Face Muscles and Tongue
I'm still having muscle spasms and my legs are painful to the touch.
1.3Patient Review
10/19/2012
Lioresal for Muscle Spasms caused by a Spinal Disease
I've been taking this medication for a few years now, and my doctors have told me that it's the best possible option for my MS. However, I haven't seen much relief in either my facial pain or MS-related pain and stiffness.
1Patient Review
11/4/2012
Lioresal for Muscle Spasms caused by a Spinal Disease
The very first pill caused me to sleep for an entire day, less half an hour. It also caused me to have a seizure. The doctor ordered me to take 10 mg 3x/day, but I only took one and it had these terrible effects on me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about lioresal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Lioresal make you sleepy?

"This medicine can cause symptoms like dizziness, drowsiness, vision problems, or clumsiness in some people. Be sure to know how you'll react before doing anything that could be dangerous if you're not alert, coordinated, and able to see well."

Answered by AI

What class of drug is Lioresal?

"Baclofen is a drug that is used to relax muscles and reduce spasms. It is often prescribed for people who have multiple sclerosis or spinal cord injuries. Baclofen can help to relieve muscle pain, stiffness, and spasms."

Answered by AI

Are baclofen pain killers?

"No, Baclofen is not a pain killer. It is a muscle relaxer that can help with pain caused by muscle spasms, but will not help with other types of pain."

Answered by AI

What is Lioresal used to treat?

"Lioresal is a medication that helps to relieve spasticity of voluntary muscle that is a result of disorders such as multiple sclerosis, other spinal lesions, motor neurone disease, transverse myelitis, andtraumatic partial section of the cord."

Answered by AI

Clinical Trials for Lioresal

Have you considered Lioresal clinical trials? We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Lioresal clinical trials? We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.Go to Trials
Image of Baylor College of Medicine/Texas Children's Hospital in Austin, United States.

Guided Imagery Therapy for Abdominal Pain

7 - 12
All Sexes
Austin, TX
Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.
Waitlist Available
Has No Placebo
Baylor College of Medicine/Texas Children's Hospital (+1 Sites)
Image of Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016) in New York, United States.

Electromagnetic Resonance Therapy for Autoimmune Diseases

Any Age
All Sexes
New York, NY
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with each other. The goal is to see if this "quantum-synaptic" signaling effect can help stabilize immune activity and reduce the number of autoimmune flare-ups in people living with conditions such as lupus, rheumatoid arthritis, or multiple sclerosis. Participants will receive either an active or a sham (placebo) LF-EMR session three times per week for twelve weeks. Each session is completely non-invasive. Blood samples will be collected to study cytokines (immune-system messenger molecules), gene-expression patterns, and electrical field coherence among immune cells. A machine-learning system will analyze these data to predict inflammation patterns and guide individualized treatment settings. All participant data will be securely recorded and time-stamped to ensure transparency and privacy. The expected outcome of the study is a measurable reduction in autoimmune flare frequency and symptom severity, along with improved understanding of how electromagnetic signaling might safely regulate immune function.
Phase 1 & 2
Waitlist Available
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)Gavin Solomon, President & CEOTruway Health, Inc.
Have you considered Lioresal clinical trials? We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security